ReleaseWire Connect

In a groundbreaking move for the health and wellness industry in Australia, MyLife365.me is a comprehensive health-tracking solution for millions. This innovative app is set to transform how Australians approach their health, focusing on combating the rising concern of fatty liver disease, a condition affecting about one in every three Australian adults.

In a time where health and wellness are over-saturated with so many ''solutions'', MyLife365.me emerges as a beacon of innovation and accessibility in liver health management. MyLife365.me is changing the game by making liver health accessible, manageable, and understandable for everyone.

Tawazun Health stands at the forefront of addressing liver disease, particularly the growing concern of fatty liver disease, with its innovative approach and use of FibroScan technology. Recognised globally for its expertise, Tawazun Health builds on extensive research, noted in over 4,800 peer-reviewed publications, to transform understanding and treatment approaches for liver health.

Mylife365.me, the innovative lifestyle app that has been positively influencing health and wellness in the UK, Canada, the US, and Australia, is now extending its reach to France and India. This expansion marks a significant milestone in Mylife.365's global mission to promote liver health and wellness.

MyLife365.Me is an innovative lifestyle app designed to revolutionise how individuals manage their liver health. This free tool offers a unique approach to daily health tracking, focusing on food, drink, and exercise choices and their impact on liver function.

Offering Unparalleled FibroScan Services to Enhance Liver Disease Diagnosis and ManagementTawazun Health, the United Kingdom's premier provider of FibroScan services, is transforming liver health management. As the only independent service offering mobile FibroScan assessments nationwide, Tawazun Health provides high-quality, accessible liver health evaluations.

The MyLife365.Me emerges as a crucial ally in combating liver disease, an ailment affecting over 100 million people in the United States. According to the American Liver Foundation, an estimated 80-100 million U.S. adults have fatty liver disease, largely due to dietary habits characterised by high consumption of processed foods, sugar, and unhealthy fats. These eating patterns contribute to obesity and type 2 diabetes, which are major risk factors for developing fatty liver disease.

In a recent and much-debated decision, the UK government has not incorporated Liver Fibroscan testing as part of the National Health Service (NHS) offerings. This decision comes amidst growing evidence highlighting the profound connection between liver health and heart disease.

Tawazun Health proudly announces Louise Campbell as its Founder and Clinical Director, an esteemed healthcare professional with over 37 years of experience in the industry. Louise's dedication to healthcare and her groundbreaking work with FibroScan® technology have made her a distinguished figure in the field.

In an exciting expansion, MyLife365.Me, the innovative life management application, is proud to announce its availability to users in the United Kingdom, Australia, and the United States. This move signifies the app's rapid growth and its commitment to cater to a global audience.